MTOR and neoplasm: Figure 8E illustrates that the high-risk group showed notable enrichment in pathways associated with tumor progression, including PI3K-AKT-MTOR signaling, MYC targets, MTORC1 signaling, and the G2M checkpoint. These findings were further confirmed by GSEA analysis (Supplementary Figure 9).